Steward Partners Investment Advisory’s Redhill Biopharma RDHL Stock Holding History

Steward Partners Investment Advisory’s Portfolio RDHL Stock Details RDHL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5	Closed	-$183	–	3653
2023 Q4	$183	Hold	5	–	–	﹤0.01%	3414
2023 Q3	$64	Hold	5	–	–	﹤0.01%	3329
2023 Q2	$150	Hold	5	–	–	﹤0.01%	3253
2023 Q1	$511	Hold	5	–	–	﹤0.01%	3175
2022 Q4	$702	Sell	5 -2	-29%	-$866	﹤0.01%	3160
2022 Q3	$4K	Sell	7 -1	-13%	-$871	﹤0.01%	2876
2022 Q2	$7K	Hold	8	–	–	﹤0.01%	2652
2022 Q1	$19K	Hold	8	–	–	﹤0.01%	2396
2021 Q4	$19K	Hold	8	–	–	﹤0.01%	2348
2021 Q3	$34K	Hold	8	–	–	﹤0.01%	2070
2021 Q2	$52K	Hold	8	–	–	﹤0.01%	3282
2021 Q1	$54.9K	Buy	8 +3	+60%	+$25.2K	﹤0.01%	1936
2020 Q4	$40K	Buy	+5	New	+$44.9K	﹤0.01%	1771
2020 Q3	–	Sell	-1	Closed	-$3K	–	2830
2020 Q2	$3K	Hold	1	–	–	﹤0.01%	2409
2020 Q1	$2K	Hold	1	–	–	﹤0.01%	2312
2019 Q4	$3K	Hold	1	–	–	﹤0.01%	2370
2019 Q3	$3K	Hold	1	–	–	﹤0.01%	2370
2019 Q2	$3K	Buy	+1	New	+$7.7K	﹤0.01%	2367
2018 Q4	–	Sell	-1	Closed	-$4K	–	1829
2018 Q3	$4K	Buy	+1	New	+$8.15K	﹤0.01%	2217

Other funds holding RDHL

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

MOS

MGO One Seven Beachwood, Ohio $4.98B AUM 22.72% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Steward Partners Investment Advisory's RDHL Position: Q1 2024 in Review

Steward Partners Investment Advisory sold out of Redhill Biopharma (RDHL) in Q1 2024, closing a stake of 5 shares — an estimated $183 sold.

Steward Partners Investment Advisory first reported a position in RDHL in Q3 2018 and held it in 19 quarters. The position peaked at $54.9K in Q1 2021. 15 funds tracked by Wall St. Rank hold RDHL as of Q1 2024.

Steward Partners Investment Advisory reported no remaining Redhill Biopharma position as of Q1 2024 after selling out during the quarter.
Steward Partners Investment Advisory sold 5 Redhill Biopharma shares in Q1 2024, an estimated $183.
Steward Partners Investment Advisory first reported a position in Redhill Biopharma in Q3 2018 and held it in 19 quarters.
Steward Partners Investment Advisory's Redhill Biopharma position peaked at $54.9K in Q1 2021.
15 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2024.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2024, filed 15 May 2024.